These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 18219714
21. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma]. Zhang SX, Deng XZ, Tang XD. Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180 [No Abstract] [Full Text] [Related]
22. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment? Sylvester RJ. Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437 [No Abstract] [Full Text] [Related]
23. Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer. Besarani D, Al-Akraa M. BJU Int; 2006 Jul; 98(1):232-3. PubMed ID: 16831177 [No Abstract] [Full Text] [Related]
24. Risk-adapted use of intravesical immunotherapy. Braasch MR, Böhle A, O'Donnell MA. BJU Int; 2008 Nov; 102(9 Pt B):1254-64. PubMed ID: 19035890 [No Abstract] [Full Text] [Related]
36. Nursing care of the patient receiving intravesical chemotherapy. Switters DM, Soares SE, White RW. Urol Nurs; 1992 Dec 14; 12(4):136-9. PubMed ID: 1465638 [No Abstract] [Full Text] [Related]
37. A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer. Gazzaniga P, Gradilone A, de Berardinis E, Sciarra A, Cristini C, Naso G, di Silverio F, Frati L, Aglianò AM. BJU Int; 2009 Jul 14; 104(2):184-8. PubMed ID: 19154503 [Abstract] [Full Text] [Related]
38. Editorial comment. Lotan Y. J Urol; 2010 May 14; 183(5):1685. PubMed ID: 20299063 [No Abstract] [Full Text] [Related]